Renata Pacholczak-Madej

12PUBLICATIONS
47CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 04, 2026
Impact of Germline BRCA1/2 Mutations on Clinical Outcomes in Metastatic Triple-Negative Breast Cancer Patients Treated with Sacituzumab Govitecan-An International CEBCC Study from Poland, the Czech Republic and Slovakia.

|May 27, 2026
Immune-Related Adverse Events of Cemiplimab Therapy in Advanced Cervical Cancer-Data from the Polish-Czech Cervical Cancer Immunotherapy Group (PCCIG-01) with a Review of the Literature.

|May 20, 2025
Real-world efficacy and safety of nivolumab and ipilimumab in metastatic renal cell carcinoma: a Polish multicenter study.

Renata Pacholczak-Madej, Artur Drobniak, Łukasz Stokłosa

|Nov 27, 2024
Time from Final Oncologist Visit to Death and Palliative Systemic Treatment Use Near the End of Life in Heavily Pretreated Patients with Luminal Breast Cancer.

Mirosława Püsküllüoğlu, Marek Ziobro, Małgorzata Pieniążek

|Jun 12, 2024
Immunotherapy in MMR-d/MSI-H recurrent/metastatic endometrial cancer.

Renata Pacholczak-Madej, Michele Bartoletti, Lucia Musacchio

|Jun 08, 2024
Malignancy in systemic lupus erythematosus: relation to disease characteristics in 92 patients - a single center retrospective study.

Joanna Kosałka-Węgiel, Renata Pacholczak-Madej, Radosław Dziedzic

Pageof 2

Frequent Collaborators

5 joint publications

Mirosława Puskulluoglu

4 joint publications

Stanisława Bazan-Socha

3 joint publications

Aleksandra Grela-Wojewoda

3 joint publications

Joanna Kosałka-Węgiel